Windtree Therapeutics Has Received A Notice Of Allowance For Its Us Patent Application 17/517530 Titled “Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure” – Patent Center – Windtree Therapeutics (NASDA – Benzinga
